Hunter-Fleming raises L6.9 million, sets up JV

Hunter- Fleming (Bristol, U.K.) raised L6.9 million ($12 million) in a series B round led by MTI Partners. Advent International; ITX; Omega Fund Management; Pharmabio Development; and the Finance South West Growth Fund also invested in the round, which was managed by Seymour Pierce. Hunter-Fleming's HF0220, a naturally occurring cytoprotective steroid, is expected to enter a Phase IIa biomarker study for mild to moderate Alzheimer's disease (AD) this quarter. ...